May 22, 2024
Patient Risk Stratification

Patient Risk Stratification Is Poised To Grow Substantially By Enhanced Diagnostic Tools

Patient risk stratification involves identifying patients’ risk levels for certain health conditions, medical issues or expensive medical costs. This helps healthcare providers and payers determine which individuals would benefit most from early intervention and care management programs.

The Global Patient Risk Stratification Market Size Is Estimated To Be Valued At US$ 1.56 Bn In 2024 And Is Expected To Exhibit A CAGR Of 22% Over The Forecast Period 2024-2031.

Patient risk stratification solutions help providers identify high-risk patients, prioritize care management resources, and implement treatment plans. These solutions analyze clinical and demographic patient data such as medical history, prescriptions, lab results and doctor visits to assess risk levels for various diseases. This analysis assists providers in segmenting their patient populations into risk tiers so that high-risk patients receive more proactive care. The growing need to curtail healthcare costs and optimize resource utilization is fueling demand for patient risk stratification tools.

Key Takeaways

Key players operating in the Global Patient Risk Stratification market are Cerner Corporation, Epic Systems Corporation, Optum, Inc., Allscripts Healthcare Solutions, Inc., IBM Corporation, Medecision, Inc., Health Catalyst, Inc., Conifer Health Solutions, LLC, Wellcentive, Inc., Zeomega, Inc., Verscend Technologies, Inc., Precisedx, Citiustech Inc., Avero Diagnostics, Lightbeam Health Solutions, LexisNexis Risk Solutions, Milliman, Inc., NVision Health, RLDatix, and Verisk Analytics, Inc.

The growing demand for value-based care is driving increased adoption of patient risk stratification. Payers and providers are under mounting pressure to improve outcomes and reduce costs. Risk stratification helps meet these competing demands by helping providers better manage high-risk, high-cost patients.

Providers are also expanding their risk stratification capabilities globally to serve international patient populations. As the healthcare ecosystem becomes increasingly data-driven, cross-border risk stratification tools and solutions are gaining prominence.

Market Key Trends

The integration of AI and machine learning capabilities into risk stratification solutions is a major trend. AI helps glean deeper insights from vast amounts of patient data to more accurately stratify individuals according to multiple disease-specific risk factors. By automating menial tasks, AI also improves clinician efficiency and workflow. Additionally,cloud-based delivery models are becoming popular for easy accessibility of risk stratification tools on any internet-enabled device.

Porter’s Analysis

Threat Of New Entrants: New companies entering the patient risk stratification market face high costs for data, technology, and human capital. Established players have significant resources and existing customer relationships.

Bargaining Power Of Buyers: Individual patients have little bargaining power, but large providers and payers can demand lower prices or push for alternative risk models.

Bargaining Power Of Suppliers: A few large health IT vendors dominate the supply of risk assessment tools and data resources, giving them strong negotiating positions.

Threat Of New Substitutes:
New methods for predictive modeling and big data analytics could challenge traditional risk stratification over time.

Competitive Rivalry: Top vendors compete intensely on product features, customer service, and expand capabilities through partnerships and acquisitions.

Geographical Regions

North America currently dominates the global patient risk stratification market in terms of value, due to established healthcare IT infrastructure and widespread adoption of risk tools by providers and insurers.

The Asia Pacific region is poised to experience the fastest growth over the forecast period from 2024 to 2031. Rapid growth of private healthcare spending and government initiatives to digitize medical records are driving new implementation of risk assessment platforms.

Geographical Regions

The North America region holds the largest share of the global patient risk stratification market currently in terms of value, owing to advanced healthcare infrastructure and early adoption of risk stratification solutions by providers and payers.

The Asia Pacific region is projected to witness the highest CAGR over the forecast period from 2024 to 2031. This can be attributed to rising healthcare expenditures, government support for healthcare IT, and growing focus on value-based care models across emerging countries.

What are the key data covered in this Global Patient Risk Stratification Market report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Patient Risk Stratification Market’s growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Patient Risk Stratification  Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behavior

:- Global Patient Risk Stratification  Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Patient Risk Stratification  Market vendors

FAQ’s

Q.1 What are the main factors influencing the Global Patient Risk Stratification market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Patient Risk Stratification Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Patient Risk Stratification market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:

  1. Source: CoherentMI, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it